在患有原发性Sjögren病的患者中,甲尼达诱导的脑病变
So Yamamoto1, Shuhei Yoshida1, Ayumi Hashimoto1
1Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.
Modern rheumatology case reports
|March 5, 2026
概括
本病例报告详细介绍了第一例由甲尼达诱导的脑病变,该病例发生在患有Sjögren原发性疾病的患者身上. 迅速停止使用甲尼达,神经症状和大脑病变迅速消失.
科学领域:
- 神经学 神经学
- 自免疫性疾病 自免疫性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 主要Sjögren病是一种慢性自身免疫性疾病,影响神经系统.
- 在原发性Sjögren病中已知有神经学并发症.
- 甲尼达诱导的脑病是甲尼达的一种罕见的不良反应.
研究的目的:
- 报告第一例梅트로尼达诱导脑病变的病例,该病例发生在患有Sjögren原发性疾病的患者身上.
- 为了突出这种患者群体中药物诱导的神经并发症的潜力.
主要方法:
- 一个74岁的妇女的病例介绍,她患有Sjögren初级疾病.
- 临床评估包括神经学检查和脑MRI.
- 停止使用甲尼达后的神经状况的监测.
主要成果:
- 患者在长时间使用美特罗尼达后出现了走路障碍,肌痛性关节障碍,面部和动力衰竭.
- 大脑MRI显示,大脑结质体和牙状核的脏中有特征性的对称病变.
- discontinuation of metronidazole导致神经系统的快速改善和MRI发现的解决.
结论:
- 这是首个报告的metronidazole诱导脑病变的病例,患者患有原发性Sjögren病.
- 它强调需要考虑原发性Sjögren病患者神经症状的药物诱导原因.
- 综合性评估对于诊断自身免疫性疾病患者的神经症状至关重要.
相关概念视频
Drug toxicity: Idiosyncratic Reactions
75
Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
75
Antiepileptic Drugs: Glutamate Antagonists
1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
Drug Toxicity: Risk factors
66
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
66
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.0K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Drug Toxicity: Allergic Reactions
80
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80
Antiepileptic Drugs: Sodium Channel Blockers
2.1K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.1K


